Product Information

CLINDAMYCIN PHOSPHATE 1% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.2961 per GM under NDC 45802066032. Its NADAC has been published 530 times since Nov 28, 2013.

FDA first approved this application on Mar 31, 2010. Its Orange Book therapeutic-equivalence code is AT.

CLINDAMYCIN PHOSPHATE 1% FOAM

clindamycin phosphate
$2.2961per GM

Strength

10 mg/g

NDC

45802066032

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090785

FDA Approved

3/31/2010

TE Code

AT

On Market Since

3/31/2010

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has been published 530 times since Nov 28, 2013, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.2961 per GM
All-time high$5.5729 (Mar 15, 2017)
All-time low$2.2625 (Jul 22, 2026)
52-week high$3.5953
52-week low$2.2625
Median price$4.5077
Average price$4.2806
Largest weekly change-26.0% (May 22, 2024)
Weeks tracked530
Tracking sinceNov 28, 2013

Price History

1W

+1.5%

1M

+1.5%

3M

-6.7%

6M

-10.8%

1Y

-36.1%

3Y

-49.1%

5Y

-52.5%

All

-36.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 17%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.2961 per GM (NDC 45802066032), effective Aug 19, 2026.

How has the price of CLINDAMYCIN PHOSPHATE 1% FOAM changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has declined 36.9%. It has been tracked across 530 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% FOAM?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has ranged from a low of $2.2625 (Jul 22, 2026) to a high of $5.5729 (Mar 15, 2017), with a median of $4.5077 per GM.

Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% FOAM?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDACIN 1% FOAM, is $1.9087 per GM — about 17% below CLINDAMYCIN PHOSPHATE 1% FOAM.

Who manufactures CLINDAMYCIN PHOSPHATE 1% FOAM?

CLINDAMYCIN PHOSPHATE 1% FOAM (NDC 45802066032) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.